文献速递腹部MRCT

钆塞酸二钠注射持续时间对动脉期肝脏MRI肿瘤强化的影响

Effect of Gadoxetic Acid Injection Duration on Tumor Enhancement in Arterial Phase Liver MRI.
PubMed 文献 · Acad Radiol · 2019-11-28

本研究在6只VX2肝肿瘤兔中比较1秒、3秒、6秒三种钆塞酸二钠注射持续时间对动脉期MRI肿瘤信号强化与CT对比剂峰值浓度的影响。结果显示三种注射时长间肿瘤MR信号强化无显著差异(p=0.87);CT上较短注射显著提高主动脉峰值浓度(p<0.01),但肿瘤峰值浓度相当(p=0.24)。注射时间越长,CT肿瘤峰值浓度与MR肿瘤信号强化的相关性越强(r分别为0.31、0.43、0.86),仅6秒注射时具统计学显著性(p=0.03)。

要点

  • 三种注射时长(1秒、3秒、6秒)间肿瘤动脉期MR信号强化无显著差异(p=0.87)。
  • 较短注射显著提高主动脉CT峰值浓度(p<0.01),但肿瘤CT峰值浓度组间相当(p=0.24)。
  • 仅6秒注射时CT肿瘤峰值浓度与MR肿瘤信号强化相关性具统计学显著性(r=0.86,p=0.03)。

核心结论

  • CT对比剂浓度估算表明,缩短注射时间虽提高主动脉峰值浓度,但未提高肿瘤峰值浓度;且注射时间越短,钆塞酸二钠动脉期MRI肿瘤信号强化与CT峰值浓度的相关性越弱。

研究设计与样本

  • 动物实验,6只VX2肝肿瘤兔;采用钆塞酸二钠增强动脉期MRI,以团注追踪技术分别行1秒、3秒、6秒三种注射持续时间;并用相同注射容量和持续时间的碘普罗胺增强时间分辨CT估算主动脉和肿瘤的对比剂峰值浓度。

关键影像表现/征象

  • 三种注射时长下肿瘤MR信号强化无显著差异(p=0.87)。
  • CT上较短注射时长显著提高主动脉峰值对比剂浓度(p<0.01)。
  • CT上三种注射时长下肿瘤峰值对比剂浓度相当(p=0.24)。

诊断标准与关键数值

  • 以碘普罗胺增强时间分辨CT估算的峰值浓度为参考,与MRI信号强化行相关性分析。
  • CT肿瘤峰值浓度与MR肿瘤信号强化的相关系数:1秒注射r=0.31,3秒注射r=0.43,6秒注射r=0.86;仅6秒注射具统计学显著性(p=0.03)。

临床应用与阅片要点

  • 动脉期肝脏MRI采用钆塞酸二钠时,缩短注射时间可能提高主动脉峰值浓度但不提高肿瘤峰值浓度。
  • 注射时间较短时,肿瘤MRI信号强化与对比剂峰值浓度的相关性较弱,阅片时需注意。
  • 作者结论基于动物实验,原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Rapid injection of gadoxetic acid has been shown not to increase tumor enhancement in arterial phase liver MRI for unknown reasons. This study aimed to investigate the effect of injection durations on peak contrast concentration in tumors and to correlate it with signal enhancement in gadoxetic acid-enhanced arterial phase MRI.

MATERIALS AND METHODS: Gadoxetic acid-enhanced arterial phase MRI was obtained using a bolus-tracking technique with injection durations of 1, 3, and 6s in six rabbits with VX2 liver tumors. The peak concentration of gadoxetic acid in the aorta and tumor was estimated by iopromide-enhanced time-resolved CT using the same injection volume and durations with those for MRI. Signal enhancement on MRI and peak enhancement on CT were compared and correlated.

RESULTS: There was no significant difference in MR signal enhancement of tumors among the 3 injection durations (p = 0.87). In CT, shorter injection durations significantly increased peak contrast concentration in the aorta (p < 0.01) but produced equivalent peak contrast concentration in tumors (p = 0.24). The longer injections resulted in the stronger correlation between peak contrast concentration in CT and MR signal enhancement in tumors (r = 0.31, 0.43, and 0.86 with 1s-, 3s-, and 6s-injection, respectively) with a statistical significance only found with 6s-injection (p = 0.03).

CONCLUSION: Estimation of contrast concentration by CT demonstrated that shorter injections did not increase peak contrast concentration in tumors despite increased peak concentration in the aorta. Furthermore, tumor signal enhancement in gadoxetic acid-enhanced arterial phase MRI was less correlated with the peak contrast concentration with shorter injections.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Tsuboyama T, Jost G, Pietsch H, et al. Effect of Gadoxetic Acid Injection Duration on Tumor Enhancement in Arterial Phase Liver MRI. Acad Radiol. 2019. PMID: 31787566. doi:10.1016/j.acra.2019.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。